T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$2.72B |
| 2 |
Bank of New York Mellon
BK
|
+$1.14B |
| 3 |
Elevance Health
ELV
|
+$979M |
| 4 |
Medtronic
MDT
|
+$893M |
| 5 |
DD
Du Pont De Nemours E I
DD
|
+$830M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$940M |
| 5 |
Trip.com Group
TCOM
|
+$644M |
Sector Composition
| 1 | Healthcare | 21.06% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.15% |
| 4 | Industrials | 11.81% |
| 5 | Technology | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Helen of Troy
HELE
$554M
| $21.4M | ﹤0.01% |
262,000
+15,100
| +6% | +$1.23M |
|
1102
CBRE Group
CBRE
$48.8B
| $21.3M | ﹤0.01% |
551,355
+4,600
| +0.8% | +$178K |
|
1103
Adverum Biotechnologies
ADVM
$63.4M
| $21.3M | ﹤0.01% |
52,658
-49,887
| -49% | -$20.2M |
|
|
ISIL
1104
DELISTED
Intersil Corp
ISIL
| $21.3M | ﹤0.01% |
1,487,582
+170
| +0% | +$2.43K |
|
1105
Autohome
ATHM
$3.48B
| $21.3M | ﹤0.01% |
484,436
+27,355
| +6% | +$1.2M |
|
1106
Larimar Therapeutics
LRMR
$336M
| $21.1M | ﹤0.01% |
+44,380
| New | +$21.1M |
|
1107
WEC Energy
WEC
$35.6B
| $21.1M | ﹤0.01% |
426,060
+36,480
| +9% | +$1.81M |
|
1108
Oil-Dri
ODC
$959M
| $21M | ﹤0.01% |
1,249,030
-2,382
| -0.2% | -$40.1K |
|
1109
Graphic Packaging
GPK
$6.14B
| $20.9M | ﹤0.01% |
1,437,013
+106,900
| +8% | +$1.55M |
|
1110
TAL Education Group
TAL
$6.67B
| $20.9M | ﹤0.01% |
+3,766,500
| New | +$20.9M |
|
|
PNY
1111
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $20.9M | ﹤0.01% |
564,940
+534,640
| +1,764% | +$19.7M |
|
|
DDC
1112
DELISTED
Dominion Diamond Corporation
DDC
| $20.8M | ﹤0.01% |
1,219,785
+1,145
| +0.1% | +$19.6K |
|
|
WGL
1113
DELISTED
Wgl Holdings
WGL
| $20.8M | ﹤0.01% |
369,125
+348,264
| +1,669% | +$19.6M |
|
1114
Golub Capital BDC
GBDC
$3.93B
| $20.8M | ﹤0.01% |
1,210,191
-66,212
| -5% | -$1.14M |
|
1115
MACOM Technology Solutions
MTSI
$9.82B
| $20.7M | ﹤0.01% |
554,690
-179,080
| -24% | -$6.67M |
|
|
AKRX
1116
DELISTED
Akorn, Inc.
AKRX
| $20.7M | ﹤0.01% |
434,849
-2,151
| -0.5% | -$102K |
|
|
CSLT
1117
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $20.6M | ﹤0.01% |
2,648,423
-719,747
| -21% | -$5.59M |
|
|
LDR
1118
DELISTED
Landauer Inc
LDR
| $20.5M | ﹤0.01% |
584,570
-113,500
| -16% | -$3.99M |
|
|
CUDA
1119
DELISTED
Barracuda Networks, Inc.
CUDA
| $20.5M | ﹤0.01% |
533,080
-12,300
| -2% | -$473K |
|
1120
F5
FFIV
$18.5B
| $20.5M | ﹤0.01% |
178,295
-1,720
| -1% | -$198K |
|
|
CNR
1121
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $20.5M | ﹤0.01% |
1,183,972
-455,160
| -28% | -$7.87M |
|
|
CALA
1122
DELISTED
Calithera Biosciences, Inc
CALA
| $20.4M | ﹤0.01% |
62,063
-1,380
| -2% | -$453K |
|
|
AVDL
1123
Avadel Pharmaceuticals
AVDL
$1.5B
| $20.3M | ﹤0.01% |
1,131,500
+3,500
| +0.3% | +$62.9K |
|
|
ATW
1124
DELISTED
Atwood Oceanics
ATW
| $20.3M | ﹤0.01% |
723,530
+6,700
| +0.9% | +$188K |
|
1125
Alamo Group
ALG
$2.49B
| $20.3M | ﹤0.01% |
321,810
-10
| -0% | -$631 |
|